Landefeld and Goldman developed a risk score that could predict the risk of a major bleeding episode in outpatients treated with warfarin. The score uses information available when the oral anticoagulant therapy is begun. The authors are from Case Western Reserve University in Cleveland and Harvard Medical School in Boston.
Parameters:
(1) age of the patient
(2) history of stroke
(3) history of gastrointestinal bleeding
(4) comorbid conditions
(5) atrial fibrillation
Parameter |
Finding |
Points |
---|---|---|
age of the patient |
< 65 years |
0 |
|
>= 65 years |
1 |
history of stroke |
none |
0 |
|
either current or past |
1 |
|
both current and past |
2 |
history of gastrointestinal bleeding |
none |
0 |
|
present |
1 |
serious comorbid condition |
none |
0 |
|
present |
1 |
atrial fibrillation |
none |
0 |
|
present |
1 |
where:
• Serious comorbid conditions included renal insufficiency, recent myocardial infarction, and severe anemia
risk score =
= SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: 6
|
|
Cumulative Incidence of Major Bleeding |
|
Score |
Risk Group |
at 12 Months |
at 48 Months |
0 |
low |
2% |
2% |
1 or 2 |
moderate |
11% |
17% |
3, 4, 5 or 6 |
high |
16% |
63% |
from page 149, Landefeld (1989)
Purpose: To predict the risk of major bleeding in an outpatient treated with warfarin using the risk score of Landefeld and Goldman.
Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical
Objective: risk factors, severity, prognosis, stage, drug interactions, dosage adjustments, response to therapy, adverse effects, overdose and reversal
ICD-10: D69,